November 2, 2017 - Fischer Medical announced the submission of its 510(k) application with the U.S. Food and Drug Administration (FDA) for clearance of the Bloom 2 Cardiac Stimulator About the author superadmin Related postsFebruary 5, 2024 – Health Canada approves Bloom 2 for use in Canada under License 110769February 26, 2024May 17-19, 2024 – FISCHER & SCHWARZER CARDIOTEK ATTEND HRS 2024 BOOTH#941/943January 24, 2024NOVEMBER 3, 2023 – Fischer attends 7th Annual International Physiology of Pacing Symposium 2023November 3, 2023SEPTEMBER 1, 2023 – FISCHER MEDICAL AWARDED ADVANCED INDUSTRIES EXPORT GRANT BY THE COLORADO OFFICE OF ECONOMIC DEVELOPMENT AND INTERNATIONAL TRADE (OEDIT)September 5, 2023Fischer completes ISO 13485:2016 / MDSAP audit and is awarded ISO 13485:2016 / MDSAP CertificateMarch 10, 2023May 19-21, 2023 – Fischer Medical at HRS 2023 Booth #518January 23, 2023
February 5, 2024 – Health Canada approves Bloom 2 for use in Canada under License 110769February 26, 2024
NOVEMBER 3, 2023 – Fischer attends 7th Annual International Physiology of Pacing Symposium 2023November 3, 2023
SEPTEMBER 1, 2023 – FISCHER MEDICAL AWARDED ADVANCED INDUSTRIES EXPORT GRANT BY THE COLORADO OFFICE OF ECONOMIC DEVELOPMENT AND INTERNATIONAL TRADE (OEDIT)September 5, 2023
Fischer completes ISO 13485:2016 / MDSAP audit and is awarded ISO 13485:2016 / MDSAP CertificateMarch 10, 2023
